| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_861a965d702a01f4c6eaa5f8f940ff37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd7ec457a9bd7a2c56afaabd60be823e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3d76215247dc7edc752cf96cc4f25a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bcff66e49c9d31de1d712b306f72799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b506189bfefcbdf9647bfe910c4cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c699d8c9a83400191fde0c2515d6a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f1ff98e1a7f0c604bfcf5839ac7b53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8548ced0900f6e35aaa5d8b430da1b81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e73f379716a9e01dc9b8a6b612bf2cef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49afab5684346cabd55eba5a0a2a5460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4c69766545ef75d2d92ac1dac6c153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5baaf4bc2757d74cf6199243703ad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75181d5f92122a664e2502d44418411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_154aafb09f1f484cea560ff455ad47b5 |
| publicationDate |
2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2703024-C1 |
| titleOfInvention |
Strain of influenza virus b/novosibirsk/40/2017-ma for studying therapeutic and preventive efficacy of antiviral preparations in vitro and in vivo |
| abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology, medical virology and can be used in investigating the effectiveness of therapeutic and preventive preparations for influenza B virus. Strain of influenza virus B/Novosibirsk/40/2017-MA is intended for studying therapeutic and preventive efficacy of antiviral preparations in vitro and in vivo. Strain is produced on the basis of the original passportized antigenic parent strain of influenza virus B/Novosibirsk/40/2017 by blind passaging through the mice lungs and passage in the MDCK cell culture. Strain is deposited in the Collection of cultures of microorganisms of the State Research Center of Virology and Biotechnology "Vector" under registration number V-811.EFFECT: strain is adapted to mice and is able to induce non-lethal influenza infection in mice, which enables to investigate therapeutic and preventive efficacy of antiviral preparations in vivo, as well as in vitro on MDCK cell culture.1 cl, 4 dwg, 2 tbl, 4 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2769672-C1 |
| priorityDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |